AGTC Genomics Driving the Future of Medical Tourism with Precision Medicine

AGTC Genomics is proud to be part of the MHTC Industry Open Day, an important platform that brings together potential partners and MHTC Elite members to explore meaningful collaborations that elevate Malaysia’s healthcare ecosystem.

The session shared key insights into the Marketing Activations 2026 and the Malaysia Year of Medical Tourism (MyMT) Campaign 2026, outlining strategic initiatives to enhance Malaysia’s global visibility as a trusted, high-quality healthcare destination—with a strong focus on the full patient journey, from arrival to recovery.

At AGTC Genomics, we see medical tourism going beyond treatment alone. Our contribution lies in integrating precision genomics, advanced diagnostics, and personalised medicine into medical tourism pathways—supporting international patients with:

• Genomics-guided diagnosis and treatment selection

• Early disease detection and preventive health screening

• Precision oncology, pharmacogenomics, and personalised wellness solutions

• Seamless collaboration with clinicians to improve outcomes and patient confidence

We also welcome the MoU signing between MHTC and AMSPA, which strengthens collaboration in integrated healthcare and wellness tourism. This alignment reinforces Malaysia’s vision of offering holistic, end-to-end healthcare experiences, where advanced medical science and wellness converge.

AGTC Genomics remains committed to supporting MyMT 2026 by positioning Malaysia as a destination where innovation, trust, and personalised care define the future of medical tourism.

We look forward to new collaborations that will shape the next chapter of Malaysia’s global healthcare journey.